104 results match your criteria: "Centre Hospitalier Général de Chartres[Affiliation]"

Background: Despite improvement in devices, in-stent restenosis remains a frequent and challenging complication of percutaneous coronary interventions.

Methods And Results: The RESTO (Morphological Parameters of In-Stent Restenosis Assessed and Identified by OCT [Optical Coherence Tomography]; study NCT04268875) was a prospective multicenter registry including patients presenting with coronary syndromes related to in-stent restenosis. All patients underwent preintervention OCT analysis, which led to analysis of in-stent restenosis phenotype, number of strut layers, and presence of stent underexpansion.

View Article and Find Full Text PDF

[Outpatient PCI in France: data from the France PCI registry].

Ann Cardiol Angeiol (Paris)

November 2024

Service de cardiologie, Centre Hospitalier de Chartres, Chartres, France.

Percutaneous coronary intervention (PCI) is the preferred method of revascularization for chronic coronary syndromes. Outpatient PCI has demonstrated, in addition to its reliability and safety, the comfort of patients and the reduction of costs that weigh on our healthcare systems. Nevertheless, it remains largely underutilized in France, with significant disparities between centers, particularly between private and public ones.

View Article and Find Full Text PDF

Beta-Blocker Interruption or Continuation after Myocardial Infarction.

N Engl J Med

October 2024

From Sorbonne Université, ACTION Group, INSERM Unité Mixte de Recherche (UMRS) 1166, Hôpital Pitié-Salpêtrière Assistance Publique-Hôpitaux de Paris (AP-HP) (J.S., P.G., N.P., K.A., G.M.), the Department of Cardiology, Hôpital Européen Georges Pompidou, AP-HP, Université Paris Cité (E.P.), FACT (French Alliance for Cardiovascular Trials) (G.L.), the Department of Cardiology, Université Paris Cité, Hôpital Lariboisière, AP-HP, INSERM Unité 942 (J.-G.D.), the Cardiology Department, Hôpital Saint-Antoine, ACTION Group, Sorbonne Université, INSERM UMRS 938 (F. Boccara), the Cardiology Department Hôpital Bichat, AP-HP (M.S.), Unité de Recherche Clinique, ACTION Group, Hôpital Fernand Widal (AP-HP) (A.D., E.V.), and SAMM (Statistique, Analyse et Modélisation Multidisciplinaire) EA 4543, Université Paris 1 Panthéon Sorbonne (A.D., E.V.), Paris, the Cardiology Department, Nimes University Hospital, Montpellier University, ACTION Group, Nimes (G.C., B.L.), the Cardiology Department, Pasteur University Hospital, Nice (E.F., N.R.), the Cardiology Department, Hôpitaux de Chartres, ACTION Group, Hôpital Louis Pasteur, Chartres (G.R., C.T.), Cardiology Department, Hôpital Centre François Mitterrand de Pau, Pau (N.D.), Département de Cardiologie, Centre Hospitalo-Universitaire (CHU) La Timone, ACTION Group, Marseille University, INSERM, Marseille (T.C., P.D.), the Cardiology Department, CHU Tours, INSERM Unité 1327 ISCHEMIA, Université de Tours, Tours (F.I.), the Cardiology Department, CHU de Toulouse, Toulouse (T.L.), the Cardiology Department, Clinique du Pont de Chaume, Montauban (T. Petroni), the Heart and Lung Institute, University Hospital of Lille, and Institut Pasteur of Lille, INSERM Unité 1011-EGID, Lille (G.L.), the Cardiology Department, CHU d'Avignon, Avignon (F. Bresoles), the Cardiology Group of the Côte Basque, Bayonne (J.-N.L.), the Cardiology Department, CHU de Dijon Bourgogne, Dijon (T. Pommier), the Cardiology Department, CHU de Montpellier, Montpellier (F.L.), the Cardiology Department, CHU Henri Mondor, Créteil (P.L.), the Cardiology Department, Centre Hospitalier (CH) Métropole-Savoie (Hôpital Chambéry), Chambéry (T.B.H.), the Cardiology Department, Groupe Hospitalier Mutualiste (GHM) de Grenoble, Grenoble (T.F.), the Cardiology Department, CHU d'Auxerre, Auxerre (F.J.), Cardiology Department, CHU Angers et UMR Centre National de la Recherche Scientifique (CNRS) 6015, INSERM Unité 1083 Equipe Physiopathologie Cardiovasculaire, Unité de Formation et de Recherche (UFR) Santé, Angers (A.F.), Grands Prés Cardiac Rehabilitation Centre, St. Denis (R.D.), the Cardiology Department, General Hospital Yves Le Foll, Saint-Brieuc (L.P.), and the Cardiology Department, Grand Hôpital de l'Est Francilien Site Marne-La-Vallée, Jossigny (M.E.K.) - all in France.

Background: The appropriate duration of treatment with beta-blocker drugs after a myocardial infarction is unknown. Data are needed on the safety and efficacy of the interruption of long-term beta-blocker treatment to reduce side effects and improve quality of life in patients with a history of uncomplicated myocardial infarction.

Methods: In a multicenter, open label, randomized, noninferiority trial conducted at 49 sites in France, we randomly assigned patients with a history of myocardial infarction, in a 1:1 ratio, to interruption or continuation of beta-blocker treatment.

View Article and Find Full Text PDF

Resilience after severe critical illness: a prospective, multicentre, observational study (RESIREA).

Crit Care

July 2024

Laboratoire de Psychologie: Dynamiques Relationnelles Et Processus Identitaires (Psy-DREPI), Université de Bourgogne Franche-Comté, EA7458, Dijon, France.

Background: Critical-illness survivors may experience post-traumatic stress disorder (PTSD) and quality-of-life impairments. Resilience may protect against psychological trauma but has not been adequately studied after critical illness. We assessed resilience and its associations with PTSD and quality of life, and also identified factors associated with greater resilience.

View Article and Find Full Text PDF

Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction.

Circ Cardiovasc Interv

June 2024

Department of Cardiology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital européen Georges Pompidou, France (E.P., D.B., N.D.).

Background: In patients with multivessel disease with successful primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction, the FLOWER-MI trial (Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction) showed that a fractional flow reserve (FFR)-guided strategy was not superior to an angiography-guided strategy for treatment of noninfarct-related artery lesions regarding the 1-year risk of death from any cause, myocardial infarction, or unplanned hospitalization leading to urgent revascularization. The extension phase of the trial was planned using the same primary outcome to determine whether a difference in outcomes would be observed with a longer follow-up.

Methods: In this multicenter trial, we randomly assigned patients with ST-segment-elevation myocardial infarction and multivessel disease with successful percutaneous coronary intervention of the infarct-related artery to receive complete revascularization guided by either FFR (n=586) or angiography (n=577).

View Article and Find Full Text PDF

Tricuspid annular plane systolic excursion over systolic pulmonary artery pressure prognostic value for in-hospital adverse events in patients hospitalized for acute coronary syndrome.

Eur Heart J Cardiovasc Imaging

August 2024

Department of Cardiology, Université de Paris Cité, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Inserm U-942, 2 rue Ambroise Paré, 75010 Paris, France.

Article Synopsis
  • The study investigated the prognostic value of the TAPSE/sPAP ratio in patients hospitalized for acute coronary syndrome (ACS), focusing on its link to in-hospital major adverse cardiovascular events (MACEs).
  • In a cohort of 481 patients, a TAPSE/sPAP ratio below 0.55 was found to significantly predict the occurrence of MACEs, with odds ratios indicating a very strong association even after accounting for other health factors.
  • The findings highlight that a lower TAPSE/sPAP ratio improves risk assessment beyond conventional factors, suggesting it could serve as a critical marker for patient prognosis during hospitalization for ACS.
View Article and Find Full Text PDF

Purpose: Critical illness is associated with long-term increased mortality and impaired quality of life (QoL). We assessed whether multidisciplinary consultations would improve outcome at 12 months (M12) after intensive care unit (ICU) discharge.

Methods: We performed an open, multicenter, parallel-group, randomized clinical trial.

View Article and Find Full Text PDF
Article Synopsis
  • A study examined the prevalence of PTSD among ICU survivors after being treated for COVID-19 compared to other causes of ICU admission, finding that 4.9% of patients in both groups had a presumptive diagnosis of PTSD six months later.
  • After adjusting for factors like age and prior trauma, COVID-19 status alone was not linked to PTSD diagnosis, although female patients were more likely to exhibit PTSD symptoms.
  • Patients treated for COVID-19 did report higher levels of specific PTSD symptoms like intrusion and avoidance when compared to those treated for other conditions, indicating different psychological impacts.
View Article and Find Full Text PDF

In-hospital prognostic value of TAPSE/sPAP in patients hospitalized for acute heart failure.

Eur Heart J Cardiovasc Imaging

July 2024

Inserm U-942, Assistance Publique-Hôpitaux de Paris, Hôpital Lariboisière, Department of Cardiology, Université de Paris Cité, 2 rue Ambroise Paré, 75010 Paris, France.

Article Synopsis
  • - The study investigated the use of the TAPSE/sPAP ratio, measured by echocardiography, to predict in-hospital major adverse cardiovascular events (MACEs) in patients hospitalized for acute heart failure (AHF) across multiple French hospitals.
  • - A total of 333 patients were included, revealing that a TAPSE/sPAP ratio of less than 0.40 mm/mmHg was independently linked to a higher risk of in-hospital MACEs, which occurred in 15% of patients studied.
  • - The findings suggest that early assessment of TAPSE/sPAP can improve risk stratification in AHF patients and may prompt closer monitoring and intervention strategies.
View Article and Find Full Text PDF

Profile of patients hospitalized in intensive cardiac care units in France: ADDICT-ICCU registry.

Arch Cardiovasc Dis

March 2024

Department of Cardiology, hôpital Lariboisière, Assistance publique-Hôpitaux de Paris, University of Paris, Inserm U-942, 10, rue Ambroise-Paré, 75010 Paris, France. Electronic address:

Article Synopsis
  • Intensive cardiac care units (ICCU) in France have diversified from monitoring arrhythmias post-heart attack to treating various cardiac conditions, with acute coronary syndromes (ACS) being the most common cause for admission.
  • A study of 1499 patients revealed that many have additional health concerns, with a significant portion requiring advanced therapies but a majority not needing invasive procedures.
  • Overall, patients tend to have brief hospital stays with a low rate of major adverse events, although acute heart failure (AHF) patients face higher risks and resource use.
View Article and Find Full Text PDF

Diabetes Mellitus across the Arabo-Islamic World: A Revolution.

Int J Endocrinol

November 2023

Endocrinology Division, Centre Hospitalier de Chartres, Louis Pasteur Hospital, Chartres, France.

Background: Mankind continues to suffer from the ever-growing diabetes epidemic and the rapid rise of type 2 diabetes mellitus (T2DM). This metabolic disease has been studied since ancient civilizations. The Arabo-Islamic civilization excelled in establishing some of the most notable discoveries and teachings that remained the blueprint for years to come in the field of diabetology.

View Article and Find Full Text PDF

The France PCI registry: Design, methodology and key findings.

Arch Cardiovasc Dis

November 2023

Sorbonne Université, Action Study Group (action-groupe.org), Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, 75013 Paris, France.

Background: Obstructive coronary artery disease is the main cause of death worldwide. By tracking events and gaining feedback on patient management, the most relevant information is provided to public health services to further improve prognosis.

Aims: To create an inclusive and accurate registry of all percutaneous coronary intervention (PCI) procedures performed in France, to assess and improve the quality of care and create research incentives.

View Article and Find Full Text PDF

P2Y Inhibitor Loading Time Before Elective PCI and the Prevention of Myocardial Necrosis.

Can J Cardiol

January 2024

ACTION Study Group, Sorbonne Université, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France.

Article Synopsis
  • The study aimed to investigate the effects of the timing of P2Y inhibitor administration on myocardial necrosis during elective percutaneous coronary intervention (PCI), utilizing data from the ALPHEUS trial.
  • Results revealed that patients who received P2Y inhibitors closer to the PCI procedure had higher rates of myocardial necrosis compared to those who were given the medication earlier, with improved outcomes seen in groups that received longer loading times.
  • While the study found a correlation between timing and myocardial injury, it noted that bleeding complications were minimal and did not vary significantly among the different timing groups, leaving long-term clinical effects unclear.
View Article and Find Full Text PDF

Background: Physical restraint is frequently used in intensive care units to prevent patients' life-threatening removal of indwelling devices. In France, their use is poorly studied. Therefore, to evaluate the need for physical restraint, we have designed and implemented a decision support tool.

View Article and Find Full Text PDF

Characterization of cortical activation patterns during movements in healthy adults may help our understanding of how the injured brain works. Upper limb motor tasks are commonly used to assess impaired motor function and to predict recovery in individuals with neurological disorders such as stroke. This study aimed to explore cortical activation patterns associated with movements of the hand and shoulder using functional near-infrared spectroscopy (fNIRS) and to demonstrate the potential of this technology to distinguish cerebral activation between distal and proximal movements.

View Article and Find Full Text PDF

Background: while the duration of dual antiplatelet therapy (DAPT) following coronary angioplasty for chronic coronary syndrome (CCS) recommended by the European Society of Cardiology has decreased over the last decade, little is known about the adherence to those guidelines in clinical practice in France.

Aim: To analyze the real duration of DAPT post coronary angioplasty in CCS, as well as the factors affecting this duration.

Methods: Between 2014 and 2019, 8.

View Article and Find Full Text PDF

Based on the latest knowledge and technological advancements, it is still debatable whether a modern revascularisation approach in the setting of acute myocardial infarction (AMI), including complete revascularisation (in patients with significant non-culprit lesions) with newer-generation highly biocompatible drug-eluting stents, requires prolonged dual antiplatelet therapy (DAPT). TARGET-FIRST (ClinicalTrials.gov: NCT04753749) is a prospective, open-label, multicentre, randomised controlled study comparing short (one month) DAPT versus standard (12 months) DAPT in a population of patients with non-ST/ST-segment elevation myocardial infarction, completely revascularised at index or staged procedure (within 7 days), using Firehawk, an abluminal in-groove biodegradable polymer rapamycin-eluting stent.

View Article and Find Full Text PDF
Article Synopsis
  • A study called the NUTRIREA-3 trial explored whether lower calorie and protein intake during the early treatment of critically ill patients could lead to better outcomes compared to standard nutrition guidelines.
  • Conducted in 61 ICUs across France, the trial involved over 3,000 patients who received either low or standard nutrition after being put on mechanical ventilation for shock.
  • Results showed no significant difference in 90-day mortality rates but indicated that patients on the low nutrition plan had a slightly quicker ICU discharge time and experienced fewer gastrointestinal issues and liver dysfunction.
View Article and Find Full Text PDF
Article Synopsis
  • Despite advancements in stent technology, there's still a notable risk of in-stent restenosis (ISR) after procedures like PCI, and comprehensive data on this issue is limited.
  • A study analyzed data from the France-PCI registry between 2014 and 2018, focusing on patients with ISR lesions, finding that 7.3% of the patients treated had ISR PCI, mostly involving older individuals with comorbidities like diabetes.
  • The results revealed that those undergoing ISR PCI had higher rates of complications after one year compared to non-ISR patients, indicating a need for further research and improved techniques in managing ISR.
View Article and Find Full Text PDF

Continued enteral nutrition until extubation compared with fasting before extubation in patients in the intensive care unit: an open-label, cluster-randomised, parallel-group, non-inferiority trial.

Lancet Respir Med

April 2023

Médecine Intensive Réanimation, CHRU Tours, CIC INSERM 1415, CRICS-TriggerSep F-CRIN Research Network, Tours, France; INSERM, Centre d'Etude des Pathologies Respiratoires, U1100, Tours, France; Université de Tours, Tours, France. Electronic address:

Background: Fasting is frequently imposed before extubation in patients in intensive care units, with the aim to reduce risk of aspiration. This unevaluated practice might delay extubation, increase workload, and reduce caloric intake. We aimed to compare continued enteral nutrition until extubation with fasting before extubation in patients in the intensive care unit.

View Article and Find Full Text PDF

Background: Severe hypoxemia in patients with COVID-19 pneumonia might result from hypoxic pulmonary vasoconstriction, contributing to ventilation/perfusion (V/Q) mismatch. Because almitrine improves V/Q, it might reduce the risk for mechanical ventilation (MV) in such patients. Our primary objective was to determine the effect of almitrine on the need for MV at day 7.

View Article and Find Full Text PDF
Article Synopsis
  • A study is being conducted to investigate the prevalence of psychoactive drug use in patients admitted to intensive cardiac care units for acute cardiovascular events across 39 centers in France.
  • Researchers will systematically test patients for illicit and non-illicit psychoactive drugs using urine assays within 2 hours of admission, alongside assessing smoking and alcohol consumption.
  • The study aims to explore the relationship between detected psychoactive drugs and in-hospital major adverse events, as well as track patient outcomes over a 12-month follow-up period.
View Article and Find Full Text PDF